Cotización ONCODESIGN
Acciones
ALONC
FR0011766229
Biotecnología e investigación médica
Directores | Puesto | Edad | Desde |
---|---|---|---|
Fabrice Viviani
CEO | Chief Executive Officer | - | - |
Arnaud Lafforgue
DFI | Director of Finance/CFO | - | 01/01/18 |
Stéphane Gerart
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/20 |
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Kamel Besseghir
BRD | Director/Board Member | 75 | 03/02/14 |
62 | - | ||
Karine Lignel
BRD | Director/Board Member | 55 | 14/05/08 |
Varia. 1 de ene. | Capi. | |
---|---|---|
+8,95 % | 45,97 mil M | |
+52,22 % | 43,93 mil M | |
+8,01 % | 42,34 mil M | |
-8,78 % | 28,27 mil M | |
+18,11 % | 27,18 mil M | |
-20,56 % | 19,44 mil M | |
+14,40 % | 13,83 mil M | |
+31,83 % | 12,4 mil M | |
+9,15 % | 11,45 mil M |